Evidence mapPaperPMID 39440022Full record

ArticlePNAS nexus2024

CODI: Enhancing machine learning-based molecular profiling through contextual out-of-distribution integration.

Tarek Eissa, Marinus Huber, Barbara Obermayer-Pietsch, Birgit Linkohr, Annette Peters, Frank Fleischmann, Mihaela Žigman

Abstract read
In one paragraph

Article in PNAS nexus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. AI alignment is all your need for future drug discovery.Frontiers in artificial intelligence · 2025
    Review
  4. The Perils of Molecular Interpretations from Vibrational Spectra of Complex Samples.Angewandte Chemie (International ed. in English) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tarek EissaChair of Experimental Physics - Laser Physics, Ludwig-Maximilians-Universität München, Bavaria 85748, Germany.ORCID https://orcid.org/0000-0002-8932-2553
Marinus HuberChair of Experimental Physics - Laser Physics, Ludwig-Maximilians-Universität München, Bavaria 85748, Germany.ORCID https://orcid.org/0000-0001-5309-4475
Barbara Obermayer-PietschDepartment of Internal Medicine, Division of Endocrinology and Diabetology, Medical University, Styria 8010, Austria.ORCID https://orcid.org/0000-0003-3543-1807
Birgit LinkohrInstitute of Epidemiology, Helmholtz Zentrum München, Bavaria 85764, Germany.ORCID https://orcid.org/0000-0002-3387-5685
Annette PetersInstitute of Epidemiology, Helmholtz Zentrum München, Bavaria 85764, Germany.ORCID https://orcid.org/0000-0001-6645-0985
Frank FleischmannChair of Experimental Physics - Laser Physics, Ludwig-Maximilians-Universität München, Bavaria 85748, Germany.
Mihaela ŽigmanChair of Experimental Physics - Laser Physics, Ludwig-Maximilians-Universität München, Bavaria 85748, Germany.ORCID https://orcid.org/0000-0001-8306-1922

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular analytics increasingly utilize machine learning (ML) for predictive modeling based on data acquired through molecular profiling technologies. However, developing robust models that accurately capture physiological phenotypes is challenged by the dynamics inherent to biological systems, variability stemming from analytical procedures, and the resource-intensive nature of obtaining sufficiently representative datasets. Here, we propose and evaluate a new method: Contextual Out-of-Distribution Integration (CODI). Based on experimental observations, CODI generates synthetic data that integrate unrepresented sources of variation encountered in real-world applications into a given molecular fingerprint dataset. By augmenting a dataset with out-of-distribution variance, CODI enables an ML model to better generalize to samples beyond the seed training data, reducing the need for extensive experimental data collection. Using three independent longitudinal clinical studies and a case-control study, we demonstrate CODI's application to several classification tasks involving vibrational spectroscopy of human blood. We showcase our approach's ability to enable personalized fingerprinting for multiyear longitudinal molecular monitoring and enhance the robustness of trained ML models for improved disease detection. Our comparative analyses reveal that incorporating CODI into the classification workflow consistently leads to increased robustness against data variability and improved predictive accuracy.

Indexed as

data augmentationmachine learningmolecular analyticsout-of-distributionvariability modeling

Identifiers

PMID39440022
PMCPMC11495219

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.